Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - ethambutol hydrochloride - film-coated tablet - 100 milligram(s) - other drugs for treatment of tuberculosis; ethambutol

Ireland - English - HPRA (Health Products Regulatory Authority)

morningside healthcare ltd - ethambutol hydrochloride - film-coated tablet - 100 milligram(s) - other drugs for treatment of tuberculosis; ethambutol

Ireland - English - HPRA (Health Products Regulatory Authority)

morningside healthcare ltd - ethambutol hydrochloride - film-coated tablet - 400 milligram(s) - other drugs for treatment of tuberculosis; ethambutol

United States - English - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - ethambutol hydrochloride (unii: qe4vw5fo07) (ethambutol - unii:8g167061qz) - ethambutol hydrochloride is indicated for the treatment of pulmonary tuberculosis. it should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety and appropriate in-vitro susceptibility studies. in patients who have not received previous antituberculous therapy, i.e., initial treatment, the most frequently used regimens have been the following: - ethambutol plus isoniazid - ethambutol plus isoniazid plus streptomycin. in patients who have received previous antituberculous therapy, mycobacterial resistance to other drugs used in initial therapy is frequent. consequently, in such retreatment patients, ethambutol should be combined with at least one of the second line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in-vitro studies. antituberculous drugs used with ethambutol have included cycloserine, ethionamide, pyrazinamide, viomycin and other drugs. isoniazid, aminosalicylic acid, and streptomycin have also been used in multiple drug regimens. alternating drug regimens have also been utilized. ethambutol hydrochloride is contraindicated in patients who are known to be hypersensitive to this drug. it is also contraindicated in patients with known optic neuritis unless clinical judgement determines that it may be used. ethambutol hydrochloride is contraindicated in patients who are unable to appreciate and report visual side effects or changes in vision (e.g., young children, unconscious patients).

United Kingdom - English - myHealthbox

peckforton pharmaceuticals ltd - ethambutol hydrochloride - film-coated tablet - 400 mg - antimycobacterial - it is indicated for the primary treatment and re-treatment of tuberculosis and for prophylaxis in cases of inactive tuberculosis or large-tuberculinpositive reaction

United Kingdom - English - myHealthbox

peckforton pharmaceuticals ltd - ethambutol hydrochloride - film-coated tablet - 100 mg - antimycobacterial - it is used for the primary treatment and re-treatment of tuberculosis and for prophylaxis in cases of inactive tuberculosis or large-tuberculinpositive reaction.

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - ethambutol hydrochloride (unii: qe4vw5fo07) (ethambutol - unii:8g167061qz) - myambutol is indicated for the treatment of pulmonary tuberculosis. it should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety, and appropriate in-vitro susceptibility studies. in patients who have not received previous antituberculous therapy, ie, initial treatment, the most frequently used regimens have been the following: myambutol plus isoniazid myambutol plus isoniazid plus streptomycin. in patients who have received previous antituberculous therapy, mycobacterial resistance to other drugs used in initial therapy is frequent. consequently, in such retreatment patients, myambutol should be combined with at least one of the second line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in-vitro studies. antituberculous drugs used with myambu

Philippines - English - FDA (Food And Drug Administration)

doctor pharma'l inc - ethambutol hydrochloride - tablet - 400mg

Philippines - English - FDA (Food And Drug Administration)

ashford pharma'l labs inc - ethambutol hydrochloride - tablet - 400mg

Philippines - English - FDA (Food And Drug Administration)

biotech research labs inc - ethambutol hydrochloride - tablet - 400mg